CTOs on the Move

Mydecine

www.mydecine.com

 
Mydecine Innovations Group™ (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) is a life sciences parent company dedicated to the development and production of adaptive pathway medicine, natural health products and digital health solutions. Mydecine`s experienced cross functional teams have the dynamic capabilities to oversee all areas of medicine development including synthesis, genetic research, import/export, delivery system development, clinical trial execution, through to product commercialization and distribution. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations, Mydecine is positioned at the forefront of psychedelic medicine naturally derived from fungi, therapeutic solutions, and fungtional™ mushroom vitality products. Our portfolio of unified companies, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mydecine.com
  • 789 West Pender Street Suite 810
    Vancouver, BC CAN V6C 1H2
  • Phone: n/a

Executives

Name Title Contact Details

Similar Companies

Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics is a focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases.

Aphios Corp

Aphios Corp is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BBRAUN Medical

BBRAUN Medical is a Cleveland, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biotix Holdings

Biotix Holdings is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Acasti Pharma

Acasti Pharma Inc. is an emerging biopharmaceutical company dedicated to the research, development and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation. To carry out this mission, Acasti is advancing its portfolio of bioactive ingredients, by purifying and concentrating krill-oil extracts through innovative technology, to produce products targeting the prescription drug and medical food markets.